Sharechat Logo

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) welcomes US FDA Complete Response Letter

Monday 9th November 2020

Text too small?

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) today announces it has received a US Food and Drug Administration (FDA) complete response letter (CRL) covering its application for the approval of a tablet version of its Maxigesic® pain relief medication.

 

In the letter, the US regulator said an FDA Good Manufacturing Practice (GMP) inspection of the tablet production facilities – delayed due to COVID-19 related travel disruptions – was the “only deficiency” with AFT’s application.

 

A CRL indicates the FDA has completed its review of a new drug application. The letter covered AFT’s application for prescription Maxigesic tablets, branded Combogesic® in the US, for treatment of mild to moderate acute pain.

 

AFT Managing Director Dr Hartley Atkinson said the CRL indicated AFT had cleared a significant hurdle on its path towards the commercialisation of the Maxigesic pain relief family of medicines in the world’s largest pharmaceutical market.

 

“This is a very pleasing result. The letter shows a prescription version of Maxigesic is approvable in the US and that AFT is well on the way to approval of its patented medicine in the US market.

 

Dr Atkinson said it was too early to say when the medicine would be approved for sale in the US. In addition to final approval from the FDA, AFT still needed to licence the medication to a distributor.

 

See the links below for more details:

 

AFT welcomes US FDA Complete Response Letter

 

Source: AFT Pharmaceuticals Limited



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Westpac Banking Corporation (NZX: WBC) Sells General Insurance Business to Allianz and Enters 20 Year Distribution Agreement
NZX Limited (NZX: NZX) Investor Day and Earnings Guidance Update
Synlait Milk Limited (NZX: SML) Sustainability Report Shows GHG Emissions Improvements
IPO Offer: New Zealand Rural Land Co
Infratil Limited 6-year Infrastructure Bonds
Allied Farmers Limited (NZX: ALF) Launch of Renounceable Rights Issue
NZ Windfarms Limited (NZX: NWF) VVFPA Document Completion and FY2021 EBITDAF Guidance Range
Property for Industry Limited (NZX: PFI) Signals Positive Valuation Outcome
SkyCity Entertainment Group Limited (NZX: SKC) Update on SkyCity Adelaide, Including Opening of Expansion
Sky Network Television Limited (NZX: SKT) Announces Chief Executive Change

IRG See IRG research reports